Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma-Reference-Cited by-同舟云学术

Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma

Published:2007-10-29 Issue:0 Volume:0 Page:071029014002001-???
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Ogawa Yoshiaki,Tobinai Kensei,Ogura Michinori,Ando Kiyoshi,Tsuchiya Takahide,Kobayashi Yukio,Watanabe Takashi,Maruyama Dai,Morishima Yasuo,Kagami Yoshitoyo,Taji Hirofumi,Minami Hironobu,Itoh Kuniaki,Nakata Masanobu,Hotta Tomomitsu

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2007.00638.x/fullpdf

Reference16 articles.

1. Standard Treatment of Multiple Myeloma

2. Management of Myeloma: Current and Future Approaches

3. Second and third responses to the same induction regimen in relapsing patients with multiple myeloma

4. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

5. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tumor effect of proteasome inhibitor on canine urothelial carcinoma;Journal of Veterinary Medical Science;2024

2. Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma;Transfusion and Apheresis Science;2023-06

3. Impact of Concomitant Use of Azoles on Bortezomib-related Adverse Drug Reactions Using JADER;Anticancer Research;2023-02-28

4. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection;Blood Advances;2021-03-31

5. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population‐based study;International Journal of Cancer;2020-07-06